NCT02086890Active, not recruiting
Electro-acupuncture and Transcorneal Electrical Stimulation (TES) for Retinitis Pigmentosa
Modulating Ocular/Retinal Blood Flow and Visual Function in Retinitis Pigmentosa
Source: ClinicalTrials.gov · Last updated 27 Feb 2026
Brief summary (registry, in English)
Measures of vision in RP patients receiving promising therapy using transcorneal electrical stimulation.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 21 (estimated)
- First submitted
- 10 Mar 2014
- Start date
- 13 Aug 2014
- Primary completion date
- Dec 2026
- Lead sponsor
- Nova Southeastern University
- Diseases
- Retinitis pigmentosa
- NCT number
- NCT02086890
What you commit to
- Study type: Interventional
- Planned participants: 21
- From 13 Aug 2014 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous acupuncture or TES treatment for RP
- Smoking, excessive alcohol, or illegal drug use
- Receiving current psychiatric care (i.e. unstable emotional and mental health status)
- Reduced general health and/or systemic medications that may diminish the potential response to the electroacupuncture treatments
Other illness
- Vision loss due to ocular diseases other than RP, cystoid macular edema, or cataracts
- Inability to understand study procedures or communicate responses to visual stimuli in a consistent manner (cognitive impairment)
- Dementia; Long or short-term memory loss
- History of excessive bleeding
- Implanted cardiac pacemaker
Other
- Very severe vision losses in both eyes (e.g., hand motions or light perception only) with difficulty performing the proposed vision tests
- Schedules do not permit participation in all study visits
- Unable to read or speak English
- Pregnancy
Who the study is looking for
- Age 18+
- Diagnosis of retinitis pigmentosa (RP)
- Best-corrected visual acuity better than 20/400 in at least one eye
- More than 20% loss of Goldmann Visual Field area (III4e test target) in at least one eye
- Able and willing to participate in all study visits for a \~4-6 month period
- Provide informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Nova Southeastern University; College of Optometry Coordinator of this site? Confirm its status | Fort Lauderdale | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.